Short communication
Left Bundle Branch Block: An Electrical Signature of Ventricular Dyssynchrony and Cardiovascular Risk
*Corresponding Author: Malvezzi J, Department of Cardiology and Internal Diseases, Poland
Copyright: © 2026 Malvezzi J, this is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation: Malvezzi J (2026) Left Bundle Branch Block: An Electrical Signature of Ventricular Dyssynchrony and Cardiovascular Risk V1(3).
Received: Dec 30, 2025
Accepted: Jan 08, 2026
Published: Jan 16, 2026
Keywords: cardiac resynchronization, electrocardiography, cardiac pathology
Abstract
Left Bundle Branch Block (LBBB) is a significant cardiac conduction abnormality characterized by delayed activation of the left ventricle due to interruption in the normal electrical pathway. Often detected incidentally on electrocardiography, LBBB may signify underlying structural heart disease and is associated with increased morbidity and mortality. This article explores the pathophysiology, etiological factors, clinical presentation, diagnostic criteria, and management strategies of LBBB. Special emphasis is placed on its prognostic implications and evolving therapeutic approaches, including cardiac resynchronization therapy. Early identification and comprehensive evaluation of LBBB are crucial in guiding appropriate clinical decision-making and improving patient outcomes.
Introduction
Left Bundle Branch Block is a disorder of the cardiac conduction system in which the transmission of electrical impulses through the left bundle branch is delayed or completely blocked. This results in asynchronous contraction of the ventricles, particularly affecting the left ventricle, which is responsible for systemic circulation. LBBB is not a disease itself but rather an electrocardiographic finding that often reflects underlying cardiac pathology.
Anatomy and Pathophysiology
The cardiac conduction system includes the sinoatrial node, atrioventricular node, bundle of His, and the right and left bundle branches. In LBBB, conduction through the left bundle branch is impaired, causing the right ventricle to depolarize first, followed by delayed depolarization of the left ventricle through myocardial cell-to-cell conduction. This leads to ventricular dyssynchrony, reduced cardiac efficiency, and potential remodeling over time.
Etiology
LBBB is commonly associated with various cardiovascular conditions, including:
-
Hypertensive heart disease
-
Coronary artery disease
-
Cardiomyopathies (especially dilated cardiomyopathy)
-
Aortic valve disease
-
Myocarditis
-
Degenerative fibrosis of the conduction system (Lev’s and Lenègre’s disease)
In some cases, LBBB may occur in individuals without apparent structural heart disease, particularly in older adults.
Diagnostic Evaluation
The diagnosis of LBBB is primarily based on ECG findings, which include:
-
QRS duration ≥ 120 milliseconds
-
Broad, notched or slurred R waves in leads I, aVL, V5, and V6
-
Absence of Q waves in lateral leads
-
Deep S waves in leads V1 and V2
Further evaluation may include echocardiography to assess structural abnormalities, cardiac MRI for detailed imaging, and stress testing or coronary angiography if ischemic heart disease is suspected.
Clinical Significance and Prognosis
LBBB is associated with an increased risk of cardiovascular events, particularly in patients with underlying heart disease. It may complicate the diagnosis of acute myocardial infarction due to masking of typical ECG changes. Additionally, LBBB can lead to mechanical dyssynchrony, contributing to the development or worsening of heart failure.
Management
Management of LBBB focuses on treating the underlying cause and managing associated complications:
-
Control of hypertension and ischemic heart disease
-
Pharmacologic therapy for heart failure (ACE inhibitors, beta-blockers, diuretics)
-
Cardiac resynchronization therapy (CRT) in patients with symptomatic heart failure and reduced ejection fraction
-
Pacemaker implantation in select cases
Cardiac Resynchronization Therapy
CRT is a key therapeutic option for patients with LBBB and heart failure. By synchronizing ventricular contractions, CRT improves cardiac output, reduces symptoms, and enhances quality of life. It is particularly beneficial in patients with a wide QRS complex and reduced left ventricular ejection fraction.
Conclusion
Left Bundle Branch Block is an important electrocardiographic finding that warrants thorough evaluation for underlying cardiac disease. Its presence can have significant prognostic implications, especially in patients with heart failure. Advances in diagnostic tools and therapies, particularly CRT, have improved the management and outcomes of patients with LBBB. Early recognition and appropriate intervention remain critical in reducing associated cardiovascular risks.
References
-
Lang, R.M.; Badano, L.P.; Mor-Avi, V.; Afilalo, J.; Armstrong, A.; Ernande, L.; Flachskampf, F.A et al. Recommendations for cardiac chamber quantification by echocardiography in adults. Eur. Heart J. Cardiovasc. Imaging 2015, 16, 233–270.
-
Moya, A.; de Isla, L.P.; Zamorano, J.L. State-of-the-Art: Noninvasive Assessment of Left Ventricular Function Through Myocardial Work. J. Am. Soc. Echocardiogr. 2023, 37, 1027–1042.
-
Risum, N.; Strauss, D.; Sogaard, P.; Loring, Z.; Hansen, T.F.; Bruun, N.E.; Wagner, G.; Kisslo, J. Left bundle branch block: The relationship between electrical activation echocardiography mechanical contraction. Am. Heart J. 2013, 166, 340–348.
-
Meisel, S.R.; Frimerman, A.; Blondheim, D.S.; Shotan, A.; Asif, A.; Shani, J.; Rozenman, Y.; Shochat, M. Relation of the systemic blood pressure to the collateral pressure distal to an infarct-related coronary artery occlusion during acute myocardial infarction. Am. J. Cardiol. 2013, 111, 319–323.
-
Melchior, B.; Frangos, J.A. Distinctive subcellular Akt-1 responses to shear stress in endothelial cells. J. Cell. Biochem. 2014, 115, 121–129.
-
Akkaya, H.; Güntürk, E.E.; Akkaya, F.; Karabiyik, U.; Güntürk, I.; Yilmaz, S. Assessment of the Relationship Between the Adropin Levels and the Coronary Collateral Circulation in Patients wıth Chronic Coronary Syndrome. Arq. Bras. Cardiol. 2022, 119, 402–410.
-
Di Minno, A.; Spadarella, G.; Prisco, D.; Scalera, A.; Ricciardi, E.; Di Minno, G. Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: Clinical translation and areas of research. Blood Rev. 215, 29, 335–343.
